Receptors, G-Protein-Coupled
"Receptors, G-Protein-Coupled" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.
Descriptor ID |
D043562
|
MeSH Number(s) |
D12.776.543.750.695
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, G-Protein-Coupled".
Below are MeSH descriptors whose meaning is more specific than "Receptors, G-Protein-Coupled".
- Receptors, G-Protein-Coupled
- Apelin Receptors
- Calcitonin Receptor-Like Protein
- Frizzled Receptors
- Glucagon-Like Peptide Receptors
- Orexin Receptors
- Receptor, Anaphylatoxin C5a
- Receptor, PAR-2
- Receptors, Adrenomedullin
- Receptors, Angiotensin
- Receptors, Bombesin
- Receptors, Bradykinin
- Receptors, Calcitonin
- Receptors, Calcitonin Gene-Related Peptide
- Receptors, Calcium-Sensing
- Receptors, Cannabinoid
- Receptors, Catecholamine
- Receptors, Chemokine
- Receptors, Cholecystokinin
- Receptors, Corticotropin-Releasing Hormone
- Receptors, Eicosanoid
- Receptors, Endothelin
- Receptors, Formyl Peptide
- Receptors, FSH
- Receptors, GABA-B
- Receptors, Galanin
- Receptors, Ghrelin
- Receptors, Glucagon
- Receptors, Histamine H1
- Receptors, Histamine H2
- Receptors, Histamine H4
- Receptors, Islet Amyloid Polypeptide
- Receptors, Kisspeptin-1
- Receptors, LH
- Receptors, LHRH
- Receptors, Lysophospholipid
- Receptors, Melanocortin
- Receptors, Melatonin
- Receptors, Metabotropic Glutamate
- Receptors, Muscarinic
- Receptors, Neuropeptide Y
- Receptors, Neurotensin
- Receptors, Odorant
- Receptors, Opioid
- Receptors, Oxytocin
- Receptors, Parathyroid Hormone
- Receptors, Pheromone
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
- Receptors, Purinergic
- Receptors, Serotonin
- Receptors, Somatostatin
- Receptors, Tachykinin
- Receptors, Thrombin
- Receptors, Vasoactive Intestinal Peptide
- Receptors, Vasopressin
- Rhodopsin
This graph shows the total number of publications written about "Receptors, G-Protein-Coupled" by people in this website by year, and whether "Receptors, G-Protein-Coupled" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 | 1999 | 1 | 0 | 1 | 2000 | 2 | 0 | 2 | 2001 | 1 | 0 | 1 | 2003 | 1 | 1 | 2 | 2004 | 1 | 1 | 2 | 2005 | 0 | 2 | 2 | 2006 | 4 | 1 | 5 | 2007 | 5 | 3 | 8 | 2008 | 4 | 3 | 7 | 2009 | 8 | 2 | 10 | 2010 | 3 | 2 | 5 | 2011 | 4 | 5 | 9 | 2012 | 5 | 2 | 7 | 2013 | 6 | 2 | 8 | 2014 | 8 | 2 | 10 | 2015 | 3 | 1 | 4 | 2016 | 4 | 1 | 5 | 2017 | 5 | 4 | 9 | 2018 | 5 | 1 | 6 | 2019 | 2 | 3 | 5 | 2020 | 6 | 4 | 10 | 2021 | 5 | 1 | 6 | 2022 | 2 | 5 | 7 | 2024 | 3 | 5 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, G-Protein-Coupled" by people in Profiles.
-
Wada T, Senokuchi T, Shi Y, Furusho T, Morita Y, Sarie M, Hanatani S, Fukuda K, Ishii N, Matsumura T, Fujiwara Y, Komohara Y, Araki E, Kubota N. Orally administrated acetate inhibits atherosclerosis progression through AMPK activation via GPR43 in plaque macrophages. Atherosclerosis. 2025 Feb; 401:119088.
-
Pacheco J, Pe?a KA, Savransky S, Gidon A, Hammond GRV, Janetzko J, Vilardaga JP. Fast-diffusing receptor collisions with slow-diffusing peptide ligand assemble the ternary parathyroid hormone-GPCR-arrestin complex. Nat Commun. 2024 12 03; 15(1):10499.
-
Zhang X, Schlimgen RR, Singh S, Tomani MP, Volkman BF, Zhang C. Molecular basis for chemokine recognition and activation of XCR1. Proc Natl Acad Sci U S A. 2024 Nov 26; 121(48):e2405732121.
-
Kotwal A, Goldner WS, Bennett RG. Role of Relaxin Signaling in Cancer: A Review. Biochem Pharmacol. 2024 12; 230(Pt 3):116634.
-
Dickinson K, Yee EJ, Vigil I, Schulick RD, Zhu Y. GPCRs: emerging targets for novel T cell immune checkpoint therapy. Cancer Immunol Immunother. 2024 Oct 03; 73(12):253.
-
Kentistou KA, Kaisinger LR, Stankovic S, Vaudel M, Mendes de Oliveira E, Messina A, Walters RG, Liu X, Busch AS, Helgason H, Thompson DJ, Santoni F, Petricek KM, Zouaghi Y, Huang-Doran I, Gudbjartsson DF, Bratland E, Lin K, Gardner EJ, Zhao Y, Jia RY, Terao C, Riggan MJ, Bolla MK, Yazdanpanah M, Yazdanpanah N, Bradfield JP, Broer L, Campbell A, Chasman DI, Cousminer DL, Franceschini N, Franke LH, Girotto G, He C, J?rvelin MR, Joshi PK, Kamatani Y, Karlsson R, Luan J, Lunetta KL, M?gi R, Mangino M, Medland SE, Meisinger C, Noordam R, Nutile T, Concas MP, Pola?ek O, Porcu E, Ring SM, Sala C, Smith AV, Tanaka T, van der Most PJ, Vitart V, Wang CA, Willemsen G, Zygmunt M, Ahearn TU, Andrulis IL, Anton-Culver H, Antoniou AC, Auer PL, Barnes CLK, Beckmann MW, Berrington de Gonzalez A, Bogdanova NV, Bojesen SE, Brenner H, Buring JE, Canzian F, Chang-Claude J, Couch FJ, Cox A, Crisponi L, Czene K, Daly MB, Demerath EW, Dennis J, Devilee P, De Vivo I, D?rk T, Dunning AM, Dwek M, Eriksson JG, Fasching PA, Fernandez-Rhodes L, Ferreli L, Fletcher O, Gago-Dominguez M, Garc?a-Closas M, Garc?a-S?enz JA, Gonz?lez-Neira A, Grallert H, Gu?nel P, Haiman CA, Hall P, Hamann U, Hakonarson H, Hart RJ, Hickey M, Hooning MJ, Hoppe R, Hopper JL, Hottenga JJ, Hu FB, Huebner H, Hunter DJ, Jernstr?m H, John EM, Karasik D, Khusnutdinova EK, Kristensen VN, Lacey JV, Lambrechts D, Launer LJ, Lind PA, Lindblom A, Magnusson PKE, Mannermaa A, McCarthy MI, Meitinger T, Menni C, Michailidou K, Millwood IY, Milne RL, Montgomery GW, Nevanlinna H, Nolte IM, Nyholt DR, Obi N, O'Brien KM, Offit K, Oldehinkel AJ, Ostrowski SR, Palotie A, Pedersen OB, Peters A, Pianigiani G, Plaseska-Karanfilska D, Pouta A, Pozarickij A, Radice P, Rennert G, Rosendaal FR, Ruggiero D, Saloustros E, Sandler DP, Schipf S, Schmidt CO, Schmidt MK, Small K, Spedicati B, Stampfer M, Stone J, Tamimi RM, Teras LR, Tikkanen E, Turman C, Vachon CM, Wang Q, Winqvist R, Wolk A, Zemel BS, Zheng W, van Dijk KW, Alizadeh BZ, Bandinelli S, Boerwinkle E, Boomsma DI, Ciullo M, Chenevix-Trench G, Cucca F, Esko T, Gieger C, Grant SFA, Gudnason V, Hayward C, Kolcic I, Kraft P, Lawlor DA, Martin NG, N?hr EA, Pedersen NL, Pennell CE, Ridker PM, Robino A, Snieder H, Sovio U, Spector TD, St?ckl D, Sudlow C, Timpson NJ, Toniolo D, Uitterlinden A, Ulivi S, V?lzke H, Wareham NJ, Widen E, Wilson JF, Pharoah PDP, Li L, Easton DF, Nj?lstad PR, Sulem P, Murabito JM, Murray A, Manousaki D, Juul A, Erikstrup C, Stefansson K, Horikoshi M, Chen Z, Farooqi IS, Pitteloud N, Johansson S, Day FR, Perry JRB, Ong KK. Understanding the genetic complexity of puberty timing across the allele frequency spectrum. Nat Genet. 2024 Jul; 56(7):1397-1411.
-
Schlimgen RR, Peterson FC, Heukers R, Smit MJ, McCorvy JD, Volkman BF. Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies. Nat Commun. 2024 May 30; 15(1):4611.
-
Kotwal A, Simpson R, Whiteman N, Swanson B, Yuil-Valdes A, Fitch M, Nguyen J, Elhag S, Shats O, Goldner W, Bennett R. Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans. Biochem Pharmacol. 2024 07; 225:116323.
-
Nguyen TT, Camp CR, Doan JK, Traynelis SF, Sloan SA, Hall RA. GPR37L1 controls maturation and organization of cortical astrocytes during development. Glia. 2023 08; 71(8):1921-1946.
-
Janetzko J, Kise R, Barsi-Rhyne B, Siepe DH, Heydenreich FM, Kawakami K, Masureel M, Maeda S, Garcia KC, von Zastrow M, Inoue A, Kobilka BK. Membrane phosphoinositides regulate GPCR-?-arrestin complex assembly and dynamics. Cell. 2022 11 23; 185(24):4560-4573.e19.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|